We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

193 hedge funds and large institutions have $391M invested in ImmunityBio in 2024 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 63 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 21

37% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 46

17% more funds holding

Funds holding: 165 → 193 (+28)

10% more capital invested

Capital invested by funds: $357M → $391M (+$34.1M)

0.91% less ownership

Funds ownership: 9.85% → 8.95% (-0.91%)

31% less call options, than puts

Call options by funds: $24.8M | Put options by funds: $35.9M

Holders
193
Holders Change
+28
Holders Change %
+16.97%
% of All Funds
2.79%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
51
Increased
63
Reduced
46
Closed
21
Calls
$24.8M
Puts
$35.9M
Net Calls
-$11.1M
Net Calls Change
-$13.2M

Top Buyers

1
Jane Street
Jane Street
New York
+$9.28M
2
UBS AM
UBS AM
Illinois
+$9.2M
3
BlackRock
BlackRock
New York
+$6.91M
4
First Trust Advisors
First Trust Advisors
Illinois
+$5.85M
5
AWM
Accurate Wealth Management
Florida
+$3.69M

Top Sellers

1
State Street
State Street
Massachusetts
-$41.7M
2
Invesco
Invesco
Georgia
-$7.95M
3
Citigroup
Citigroup
New York
-$6.72M
4
Rafferty Asset Management
Rafferty Asset Management
New York
-$5.77M
5
PA
Perceptive Advisors
New York
-$5.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
51
Citigroup
New York
$689K -$6.72M -1,019,460 -90%
Wells Fargo
52
Wells Fargo
California
$648K +$322K +48,790 +91%
Tudor Investment Corp
53
Tudor Investment Corp
Connecticut
$639K +$666K +101,046 New
BHCM
54
Brevan Howard Capital Management
Jersey
$612K +$638K +96,765 New
MIC
55
Meridian Investment Counsel
California
$609K – – –
State of Wisconsin Investment Board
56
State of Wisconsin Investment Board
Wisconsin
$607K -$424K -64,341 -40%
Manulife (Manufacturers Life Insurance)
57
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$596K +$84K +12,738 +16%
Millennium Management
58
Millennium Management
New York
$591K +$259K +39,242 +72%
WE
59
Wealth Effects
Massachusetts
$553K +$145K +22,000 +34%
PAG
60
Private Advisor Group
New Jersey
$549K +$504K +76,407 +728%
Mirae Asset Global ETFs Holdings
61
Mirae Asset Global ETFs Holdings
Hong Kong
$529K +$548K +83,109 New
MIM
62
MetLife Investment Management
New Jersey
$520K +$88.7K +13,446 +20%
BCM
63
Bayesian Capital Management
New York
$519K +$541K +82,100 New
BRWA
64
B. Riley Wealth Advisors
Florida
$515K +$538K +81,550 New
CUAMC
65
China Universal Asset Management Company
China
$514K -$310K -47,071 -37%
PA
66
Profund Advisors
Maryland
$507K -$799K -121,163 -60%
CF
67
Corebridge Financial
Texas
$482K +$503K +76,240 New
Osaic Holdings
68
Osaic Holdings
Arizona
$473K +$209K +31,697 +73%
RG
69
Rathbones Group
United Kingdom
$464K – – –
CFO
70
Collective Family Office
Pennsylvania
$445K +$464K +70,355 New
OAC
71
OMERS Administration Corp
Ontario, Canada
$444K +$464K +70,300 New
HF
72
HRT Financial
New York
$428K +$447K +67,782 New
TI
73
Tidal Investments
Wisconsin
$406K -$188K -28,584 -31%
Invesco
74
Invesco
Georgia
$386K -$7.95M -1,206,127 -95%
Squarepoint
75
Squarepoint
New York
$385K +$402K +60,936 New
1 2
3
4 5

IBRX Hedge Fund Activity: Q2 2024 in Review

193 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q2 2024, worth a combined $391M — up 9.6% from $357M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new IBRX positions and 21 closed out — a net gain of 30 holders — while 63 added to existing stakes and 46 trimmed.

The largest buyer was Jane Street, adding an estimated $9.28M. The largest seller was State Street, cutting an estimated $41.7M.

  • 193 institutional investors held ImmunityBio (IBRX) as of Q2 2024, up from 165 in Q1 2024.
  • Funds reported $391M of ImmunityBio stock for Q2 2024, up 9.6% quarter-over-quarter.
  • 51 funds opened new ImmunityBio positions in Q2 2024 and 21 closed out, a net change of +30 holders.
  • The largest ImmunityBio buyer in Q2 2024 was Jane Street, an estimated $9.28M added.
  • The largest ImmunityBio seller in Q2 2024 was State Street, an estimated $41.7M sold.

Based on aggregated 13F filings for Q2 2024.